Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


P&G Could Lean Toward OTC Brand Sales With Activist Investor Influence

Executive Summary

Analysts consider the potential for P&G splitting up or selling OTC or beauty care assets following CEO David Taylor's recent comments on possible moves with activist investor Trian. Analysts weigh in on the potential for sale or swap of brands and whether the moves would help.


Related Content

Activist Investor Forces P&G's Hand: Shareholder Vote On Joining Board
P&G Announces 'Irresistible Superiority' Strategy To Win In Global Slump
P&G Portfolio Rationalization Brushes Off 20% Of Oral Care SKUs
Coty Wraps P&G Merger, Projects Return To Growth In FY 2017 Back Half
P&G CEO Pledges Driving Top-Line Growth With Consumer-Centric Focus
P&G Looks To “Transform” Categories, But Ackman Presses For Results


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts